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DETECTION OF COCAINE AND ITS MAJOR METABOLITES IN BONE 
FOLLOWING OUTDOOR DECOMPOSITION AFTER CHRONIC COCAINE 
ADMINISTRATION USING 2D-LC/MS/MS 
 
 
MALORIE ANN MELLA 
 
ABSTRACT 
In the field of forensic toxicology, several challenges exist with quantification 
analysis of cocaine and metabolites in post mortem samples. Cocaine can prove difficult 
to detect and quantify in blood, urine, and soft tissues following extensive decomposition. 
Alternative matrices, such as hair, nails, and bone could prove useful in detecting chronic 
drug use in post-mortem toxicology cases. Detection and quantification of drugs in 
complex matrices is difficult to accomplish due to time-consuming extraction processes, 
and inability to detect an analyte at trace levels. Further, analysis of drugs in hard tissues, 
such as hair and bone, has only been attempted in recent years. Even fewer studies have 
investigated detection of drugs following decomposition of remains, specifically outdoor 
decomposition. The objective of this study was to develop a robust extraction and clean 
up methodology, in which a homogenization step precedes, to efficiently extract drugs 
from complex matrices, reach a target limit of detection (LOD) and to maintain 
instrument performance using multidimensional chromatography. Multi-dimension 
chromatography platform such as two dimensional liquid chromatography tandem mass 
spectrometry ( 2D-LC/MS/MS,)  offers options not compatible with single dimension  
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units. With large volume injection capabilities of aqueous and organic extracts, the 
analytical process be reduced from multiple hours to minutes.   
All rat specimens used for this study fell under an Institutional Animal Care and 
Use Committee (IACUC) protocol. The rodents underwent a 10-12 weeks chronic 
intravenous self-administration of cocaine. This was followed by a six-week period of 
abstinence, followed again by a three-week period of cocaine self-administration before 
being euthanized. Average daily dosages for each rat fell within a range of 13-19 mg/kg. 
A total of 14 cocaine positive rats were placed outside and above ground in the Boston 
University Forensic Anthropology Outdoor Research Facility (Holliston, MA, U.S.A) for 
a period of 12 months. All recoverable skeletal samples were collected for testing. Drug 
free control rat bones were also acquired by placing drug-free rats outdoors, above 
ground, until full decomposition occurred. In this study, a method analyzing cocaine and 
its major metabolites benzoylecgonine and ecgonine methyl ester was developed.  
After homogenization of whole bones, the extraction process was performed 
using a mixed mode reversed-phase/ion exchange sorbent. The use of a 2D LC/MS/MS 
technology eliminates the need for a lengthy evaporation step in the extraction method. 
The chosen 2D LC/MS/MS used in this application was identified using a 6x6 automated 
method development protocol. The manual extraction of the bone samples was completed 
in less than an hour. The analysis was performed using 100µL of the final organic solvent 
(MeOH) extracts.  
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The limit of quantitation (LOQ) for cocaine and benzoylecgonine was measured 
at 0.05ng/g (0.05ng/mL or 50pg/g) of sample material and the LOQ for ecgonine methyl 
ester was measured at 0.1ng/g (0.1ng/mL or 100pg/g). The extraction method for cocaine 
proved to give a linear dynamic range of 2.5 orders of magnitude (0.05ng/g to 10ng/g 
with an R
2
 = 0.998.   
 The micro extraction protocol combined with a multi-dimension chromatography 
used in this study decreased sample preparation time without sacrificing the quality seen 
with current single dimension chromatography techniques. The procedure developed in 
this study can be utilized on bone and completed in less than an hour before injection into 
the 2D-LC/MS/MS system.  
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1. INTRODUCTION 
1.1 Post-mortem Toxicology 
In forensic cases, one of the most vital tools a medical examiner has is 
toxicological analysis. By testing blood, urine, gastric fluid, vitreous fluids, and less often 
brain and other tissues, one may be able to determine cause and/or manner of death or if 
the victim was poisoned or impaired at the time of death. The decomposition process of 
the human body poses a major hindrance to toxicological analysis. The process of 
decomposition includes the onset of autolysis, putrefaction and postmortem 
redistribution. Autolysis occurs due to naturally present enzymes in the body, in 
particular the pancreas and gastric mucosa; and putrefaction is destruction of cells and 
tissues by microorganisms. Whether due to the natural metabolic actions of the human 
body, stability of the drug itself, alkaline conditions of a decomposing body, chemical 
changes, bacteria or enzymatic activity, severe putrefaction and autolysis of a human 
body will make any analysis of drugs or poisons in tissues and body fluids very difficult 
(1). Many studies have shown that the ability to detect and accurately quantify target 
analytes such as drugs of abuse or pesticides in body tissues and fluids severely decline 
the longer the decomposition process (1).  
In some cases, the victim’s body may be so badly decomposed, to the point of 
complete skeletonization, prohibiting toxicological screening. In these cases, 
investigators must turn to alternative tissues for testing such as hair, nails, and bone. 
However, these tissues are less often employed due to the difficulties associated with 
sample preparation. 
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1.2 Alternative matrices for toxicological testing 
1.2.1 Hair as an alternative matrix 
 Nails and hair are examples of keratinized tissues which are known to retain drugs 
and heavy metals for longer periods of time. These harder tissues are also more resistant 
to decomposition and are more durable samples. Hair specimens, in particular, are very 
useful to test for chronic drug use or exposure to heavy metals or toxins (1).  Capillary 
blood surrounding the hair germination, skin/gland secretions, and external environment 
factors all provide entry points for substances to reach the growing hair matrix (2). The 
greatest advantage of drug testing keratinized tissues such as hair or nails over typical 
bodily fluids is stability of drugs in hair and nails. Samples can typically be stored at 
room temperatures for long periods of time without major degradation of drugs which 
have been incorporated into the matrix (3). Additionally, segmental hair analysis can 
provide a retroactive drug history and provide long-term history of drug use when there is 
no prior history or confirm self-reported histories. For example, forensic analysis of 88-
cm-long cut of dreadlocks of a deceased individual demonstrated increased usage of 
heroin over time followed by a period of abstinence before further toxicology testing of 
fluids indicated heroin use—which assisted officials in concluding that cause of death 
was an accidental heroin overdose (2). This makes hard matrices very useful in both fresh 
postmortem cases and after soft tissues has decomposed beyond drug testing capabilities. 
The disadvantage of drug testing in hair is that results can only provide a historical 
account of drug usage (4). Unlike blood or plasma concentrations, the concentration of 
drug in the hair itself is not an accurate indicator of the dosage of drug consumed.  
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1.2.2 Bone as an alternative matrix  
Bone is a hard tissue composed of hydroxyapatite and collagen, which further 
develops into compact and cancellous bone. Areas of cancellous bone constitute sites of 
red marrow which produce red and white blood cells and platelets. It also contains yellow 
marrow which is a reserve of fat cells found in the medullary cavity, the hollow inside of 
bone shafts. The periosteum, a thin tissue which covers the outsides of bones, is a tough, 
vascularized membrane that nourishes bone. The more porous cancellous bone receives 
nutrition from surrounding blood vessels in the body. Compact bone consists of cells with 
Haversian system, which consist of canals through which blood, lymph, and nerve fibers 
pass. Bone is also in a constant state of remodeling, which incorporates bone building 
cells. Clearly, bone and bone marrow is highly vascularized and nourished in the body, 
yet they are well protected from the environment. It survives intact for a greater length of 
time than any soft tissue in the body. Bone marrow, also used for toxicological testing, is 
protected by both the periosteum around the bone and the bone itself. It is safe from 
putrefaction as the body decomposes, however the hard bone itself is what persists for 
thousands of years intact. Therefore, it is a suitable option for toxicological screening. It 
is an obvious choice for forensic testing when human remains are in an extreme state of 
decomposition.  
An additional disadvantage to using hair for toxicological analysis is that it can be 
extremely variable from person to person. Many factors can affect drug incorporation 
into hair and subsequent detection such as chemical treatments, melanin content, and 
pigment content in hair (5), all factors which vary from person to person. Bone is not 
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exposed to the environment as easily as hair. It is not dyed or altered. During 
decomposition, most environmental and putrefaction byproducts will not penetrate every 
layer of bone. Hair is decidedly more fragile when exposed to such extreme an 
environment.  
Until recent years, it was unclear as to whether drugs are distributed in skeletal 
tissues and whether they can be detected at various time points after death. Bone does not 
grow the way hair does, and the way in which drugs are incorporated into the bone itself 
is not specifically known. There are many routes in which drugs may incorporate itself 
into the bone material itself. Bone formation takes place throughout one’s entire life—
bone formation or resorption cells are constantly working to build, remove and replace 
bone cells according to an individual’s lifestyle. The first way is that drugs travel through 
the body, and by way of the highly vascularized periosteum, surrounding blood vessels, 
or Haversian canals, they are absorbed into the available surfaces or incorporated into the 
bone building cells responsible for remodeling. It is also possible that drugs are absorbed 
into bone surfaces during decomposition when there is total breakdown of soft tissues. 
Regardless of how drugs enter the bones themselves, it has become clear that it is 
possible to detect drugs of abuse in bone samples (6-17).  
 Studies utilizing rat bones or porcine bones have shown drugs of abuse such as 
ketamine, diazepam, citalopram, amitriptyline, colchicines, meperidine, tramadol, and 
pentobarbital are still detectable in bones after decomposition with drug regiments 
ranging from one dose to chronic exposure (6-17). A forensic case involving human 
skeletal remains found in a riverine environment included toxicology testing on bones, 
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which revealed the presence of diazepam and nordiazepam (18). This case also 
demonstrates the stability of compounds of interest in the bone matrix, despite 
environmental changes. Cases in which human skeletal remains were used for 
toxicological testing are otherwise very limited.  
1.3 Cocaine 
Cocaine, also known as methylbenzoylecgonine, is an alkaloid psychotropic drug 
derived from the South American Andes Erythroxylon coca plant. The Drug Enforcement 
Administration’s Controlled Substances Act classifies cocaine as Schedule II, meaning it 
has high potential for abuse, but also some medicinal uses (4). It is commonly 
administered as a topical anesthetic for ear, nose, and throat surgery. Cocaine has the 
ability to block reuptake of dopamine, neurotransmitters, norepinephrine and serotonin in 
the brain. Desired effects of cocaine include euphoria, sexual excitement, and self-
confidence whereas negative effects range from paranoia to hallucinations. Symptoms of 
chronic cocaine use include central nervous system stimulation, psychosis, respiratory 
dysfunction, rhinitis and more (4).  
A 2013 National Survey on Drug Use and Health reported that there were 1.5 
million persons aged 12 or older who were current users of cocaine (19). The number of 
persons who had cocaine dependence or abuse in 2013 is 0.3% of the population or 
855,000 individuals. Though this survey shows a decrease in percentage of youths 
abusing cocaine between 2002 and 2013, it also shows that youths consider cocaine 
easier to obtain than in previous years (19).  
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After consumption, cocaine is rapidly distributed throughout the bloodstream, 
with about 90% of the compound binding to plasma proteins (20). Cocaine is primarily 
metabolized to benzoylecgonine via spontaneous hydrolysis at alkaline pH and ecgonine 
methyl ester via enzymatic hydrolysis by pseudocholinersterase. Both metabolites can 
also be derived via liver carboxylesterases (4).  
 Cocaine is the perfect candidate to consider testing for in alternative matrices such 
as hair, nails and bone because it is commonly abused in a chronic regiment. Because 
users tend to abuse this drug chronically, it has more time to become incorporated into 
the cell growth associated with hair and bone remodeling. Also, cocaine is very unstable 
in soft tissues and biological fluids. It has a half-life range of 0.5-1.5 hours in plasma 
(20). Cocaine and benzoylecgonine have been shown to degrade over time in blood 
samples at room temperature, and as much as 37% loss in urine samples stored at -20
o
C 
for one year (21).  
1.3.1 Testing for Cocaine in Hair 
Few studies have been conducted concerning how long cocaine and its 
metabolites can be detected in hard tissues, such as hair, after consumption. Studies 
conducted using animal test subjects have shown that cocaine is quickly incorporated into 
hair after initial intake of the drug, and disappearance from hair is dose dependant (22). 
There is evidence that cocaine can remain very stable in hair after long periods of times. 
For example, cocaine has been detected in an analysis of hair of ancient remains of a 
Peruvian mummy (4). Another study has compared the concentration of cocaine in hair 
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before and after thermal straightening and found that while cocaine itself is degraded, 
metabolite concentration increases (23).  
1.3.2 Testing for cocaine in Bone 
There is a distinct lack of research studying cocaine and metabolites in skeletal 
remains. It has not been investigated whether cocaine, an otherwise very unstable 
compound, is still detectable in bones after decomposition or even immediately after 
death. This represents a large gap in the available research. It is important for future 
forensic cases to determine what drugs can be detected in alternative matrices in extreme 
cases of decomposition and potentially how long they will persist.  
1.3.3 Toxicological Analysis tools  
 Hyphenated instrumentation, particularly liquid chromatography tandem mass 
spectrometry (LC-MS/MS) is widely used in forensic and clinical toxicology, particularly 
due to the need for high specificity and sensitivity (24). It is an approved confirmation 
method when screening for drugs of abuse in forensic laboratories as well as for 
quantitation (4, 25).  LC/MS is a more flexible technique as it is ideal for more polar and 
thermolabile compounds whereas gas chromatography-mass spectrometry (GC/MS) can 
only analyze volatile compounds. It is amenable to diverse compounds and sample types. 
Additionally, it provides precise and reproducible quantitation. The drawback to LC/MS 
is that matrix effects from samples can severely alter results (24). Matrix effects are the 
enhancement or suppression of an analyte of interest due to the sample in which it is 
encased in. By incorporating sample clean-up methods prior to analysis and isolating the 
analyte of interest, matrix effects associated with complex samples can be reduced.  
  
8 
1.4 Instrument Theory 
1.4.1 Liquid Chromatography 
Liquid chromatography is a chemical separation process by which compounds 
dissolved in a liquid mobile phase are introduced to a stationary phase, which is in the 
form of an analytical column (26). The analytical column is typically a stainless steel 
tube packed with a solid material, which provides a surface for analyte interaction (26). 
Column materials range from porous silica to polymeric materials. Depending on the 
chemical compounds of the dissolved compound, they will have a higher affinity or 
greater interaction with the mobile phase or the stationary phase and elute from the 
analytical column accordingly.  
High-performance liquid chromatography (HPLC), also known as high-pressure 
liquid chromatography, is a powerful separation method which utilizes very small 
particles in the stationary phase and very high pressure to force the mobile phase through 
the column (27). HPLC analytical columns use particle sizes around 2.5µM and higher. 
Ultra-performance liquid chromatography (UPLC) is the same technique as HPLC, 
except analytical columns consist of sub 2µm sized particles. Smaller particle size 
requires instrument operation with high pressure capabilities—typically above 6000psi. 
Separation efficiency is much higher in UPLC systems because smaller particle size in 
the analytical column allows for easier diffusion of analytes among particle surfaces.  
Reverse-phase chromatography is among the most used separation modes for low-
molecular-weight compounds, such as drugs of abuse (28). Reverse-phase 
chromatography applies a non-polar stationary phase and a relatively polar solvent. In 
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this case, non-polar compounds are typically eluted later than polar compounds due to a 
stronger retention of non-polar compounds on the non-polar stationary phase (27). 
Commonly encountered reverse-phase analytical columns are silica-based, such as C18. A 
C18 type bonded phase is prepared by combining silica with a reactive silane that carries 
an 18 carbon chain (28). C18 columns have a wide range of application uses, from 
forensic to food and environmental, and are typically a good place to start when choosing 
analytical columns. 
1.4.2 Mass Spectrometry  
Typically, UPLC or HPLC systems are coupled to some kind of detector, such as 
a mass spectrometer. Mass spectrometry is a device which filters and separates mass 
fragments. After chromatographic separation, the sample is introduced to the mass 
spectrometer, which is under vacuum, where it is ionized, fragmented, and then the ions 
are separated based on their mass-to-charge ratio (29). The core instrumentation used for 
identification and quantitation of drugs and metabolites is liquid chromatography tandem 
mass spectrometry with electrospray ionization. Electrospray ionization (ESI) is a soft 
ionization technique which can fragment molecules into reproducible patterns (29). When 
the liquid sample reaches the ion source, a charge is applied to the droplet. Then, the 
drops are de-solvated by heated gases flowing into the source. The droplet is vaporized, 
charged and dispersed into positive or negative, depending on the polarity of the source, 
gaseous ions and ion/molecule clusters (29). Finally, the ions enter the sample cone.  
Tandem mass spectrometers combine multiple mass filters in a chain within one 
instrument. After electrospray ionization, ions are focused in a tight beam into the first 
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quadrupole, known as Q1 or M1, which can be set in a scan mode to see all ions which 
pass into this quad or static mode to allow passage of a single ion per compound. The 
parent or precursor ion is discovered by conducting a Q1 scan. The precursor ions then 
enter the second quadrupole which is the collision cell. The cell is pressurized with argon 
gas which fragments the precursor molecule. After fragmentation, the ions move into the 
third quadrupole where they can be selectively filtered before being sent to the detector. 
The process from start to finish is known as multiple reaction monitoring (MRM). Using 
HPLC or UPLC and then selectively isolating and filtering ions using a triple quadrupole 
mass spectrometer allows for low detection limits in ppb (parts per billion) or less.  
1.4.3 Two-Dimensional Liquid Chromatography 
Multi-dimensional liquid chromatography employs the use of more than one 
separation column in one run (30). For example, a 2D-LC/MS/MS system will consist of 
two columns, or two dimensions, both of which could contain very different chemistries 
or separation modes. The biggest advantage of 2D chromatography is the potential to 
increase resolving power of analytes in a sample by incorporating a more chemically 
selective or higher resolution column on the second dimension (31). Traditional one-
dimensional (1D) LC methods that employ a single column lack the versatility needed to 
analyze more complex samples. This is also due to the fact that only aqueous samples can 
be injected into the system. Full automation control is also possible with some multi-
dimensional systems, which gives users the ability to automate the method development 
process (32).  
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The 2D-LC/MS/MS system utilized for this research incorporated a “Trap and 
Elute with At-Column Dilution” concept (32). This is a simple upgrade from a single 
dimensional system. All that is needed is an extra pump, valve, and a trapping column 
(32). The second pump is utilized for the at-column dilution concept. The dilution is 
performed by combining one stream connected to the injector port, the loading stream, 
and a dilutor stream to a low volume mixer. The flow rates of each stream are set to 
produce a desired dilution ratio of less than 5% (32). The diluted sample then flows onto 
the trap column, the first dimension, where all analytes of interest are captured. The 
dilution of the sample is necessary to prevent breakthrough of the analytes. The trap 
column is packed with large particles, greater than 10 µm. The capture of analytes 
depends on the chemical makeup of the compounds themselves, the chemistry of the 
trapping column, additives during the loading phase, and optimized flow rates. Large 
sample injections are possible using a 2D system, up to 1mL, because of the large particle 
size of the trap column and the pressure capacity of UPLC pumps. On a 1D system, only 
very small volumes can be directly injected without adversely affecting the 
chromatography, especially if the sample is in any percentage of organic solvent (33). 
Samples injected into a one dimensional system must be aqueous based, since high 
percentages of organic solvent will prevent retention of analytes onto the analytical 
column because a compound dissolved in an organic solvent will have more interaction 
with the solvent than the stationary phase. This is a concept called breakthrough. The at-
column dilution concept allows the user to inject any solvent, from aqueous to organic, as 
well as larger volumes. For example, if a sample dissolved in 100% acetonitrile was 
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injected, it would first be diluted with water to less than 5%, which is a low enough 
percentage to prevent breakthrough. After the compounds of interest are trapped on the 
first dimension, the trap column is re-positioned into the elution stream where a backflush 
elution is performed (32). The backflush elution will flow into the higher resolution 
analytical column second dimension before flowing to the detector of choice.   
1.4.4 Comparison of 1D and 2D sample prep methods 
 For one dimensional chromatography, sample preparation methods typically use, 
at the very minimum, a solid phase extraction, solid-liquid extraction, or liquid-liquid 
extraction, followed by an evaporation and reconstitution step before injection into the 
LC-MS/MS. Researchers who have worked with more complex matrices will use a solid-
liquid extraction, evaporate to dryness, reconstitute, and then use a solid phase extraction 
method for further clean up. One such method used to extract drugs of abuse in bones 
first employs sonicating the bones in 0.25M NaOH for 60 minutes, followed by a rinsing 
or washing step. Next, the bones were pulverized using a general purpose grinder or 
mortar and pestle. The ground up bone material was incubated in methanol at 50
o
C for 72 
hours, evaporated, and reconstituted in an aqueous solvent. The reconstituted extract 
underwent a solid phase extraction step, a second evaporation to dryness, and finally 
reconstitution in water before injection onto an LC/MS/MS (8, 10). This method takes a 
minimum of 74 hours to complete. Other publications have increased the incubation time 
to 96 hours (17). Methods in the literature used for extraction of drugs of abuse in bone 
use the previously mentioned method, with some additional steps such as storage at -20
o
C 
for one hour to precipitate lipids and proteins (6-18). The fastest method for extraction of 
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bones in the literature utilizes a microwave assisted extraction which takes about 15 
minutes (11, 13, 14). However, the extract produced from this procedure was for 
immunoassay screening. The authors go on to perform a 72 hours incubation of the 
sample before UPLC/MS/MS or GC/MS confirmation. Analysis of hair samples utilize a 
similar method of a solid-liquid extraction followed by a solid phase extraction 
procedure, except with shorter incubation times of about 4 hours (5). Clearly, analysis of 
hard tissues such as bone or hair requires a large amount of time and work, which would 
prevent implementation of such methods into current forensic laboratories. Interestingly, 
the authors of these methods never explain why a prolonged incubation step is necessary 
for analysis of harder tissues. For analysis of softer tissues than bone or hair, such as 
heart, liver, or kidney, the simplest method seen in the literature employs a solid-liquid 
extraction of the tissue, followed by evaporation to dryness, reconstitution and direct 
injection into the LC/MS/MS (34). The problem with this method is that the lack of 
further sample clean up will most likely cause ion suppression or enhancement effects. 
Additionally, an evaporation to dryness step will still add one or two hours to a method.  
 The largest hurdle to analyzing complex matrices such as hair or bone or human 
tissues is the time consuming aspect of the sample preparation methods as well as the 
extra effort required to properly clean up the sample and isolate the analyte of interest. 
One of the biggest advantages to using a 2D-LC/MS/MS system is that it offers much 
more flexibility than a 1D system. For example, it is capable of larger injection volumes 
and the ability to inject 100% organic solvent. The ability to inject organic solvents 
means that any evaporation to dryness steps can be eliminated from a sample preparation 
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method, which automatically reduces preparation time by hours. Evaporative loss or 
redissolution issues are then no longer applicable. The extra pump, valve, and columns 
coupled with an automation capability means that the user can test different loading 
conditions, elution conditions, and trapping materials all within one overnight run, 
approximately 18 hours, to find the best chromatography method (35). By analyzing the 
data, the user can figure out if the compound of interest prefers to be trapped as an 
ionized or neutral species, as well as what solvent it is dissolved in—water, methanol, 
acetonitrile, acetone—will give the best response. All of these details will assist the user 
in the sample preparation method development. A two-dimensional approach has the 
potential to produce a multi-residue chromatography method and sample preparation 
method which gives a greater than 90% recovery for all compounds (35).  
1.5 Research Objective 
The objective of this research is to investigate whether cocaine and its major 
metabolites can be detected in bone samples after a year of decomposition and a second 
year of storage in room temperature conditions.  This research will incorporate 2D-
LC/MS/MS technology with a rapid extraction method for an overall goal runtime of less 
than one hour. 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Instrumentation – 2D-LC/MS/MS 
For the purposes of this research, an ACQUITY UPLC® was used, with a 2D 
configuration for “Trap and Elute” with at-column dilution. The configuration was 
constructed with two Binary Solvent Managers (BSM)—one set for gradient elution and 
one set for “At-column” dilution.  The at-column dilution pump was plumbed to create 
two streams. The A side was set for loading the extracts from the injection loop onto a 50 
µL mixer, while the B side was set at high flow rate for dilution. A re-focusing effect on 
a trap column follows before the molecules are re-focused a second time onto the 
analytical column. The final elution of the extracts flows into the mass spectrometer for 
detection. The 2D-LC/MS/MS setup is depicted below (Figure 1). The detector used with 
the chromatography system was a Xevo TQD (Waters Corporation, Milford, MA, U.S.A) 
mass spectrometer.  
MassLynx© version 4.1 (Waters Corporation, Milford, MA, U.S.A.) software was 
utilized to view and analyze all chromatograms and spectra referenced throughout this 
research, as well as control all instrumentation. TargetLynx© version 4.1 (Waters 
Corporation, Milford, MA, U.S.A) software was utilized for all quantitation performed 
throughout. Signal intensities were evaluated by measuring the area count of the peaks 
produced in the chromatograms. Each sample was analyzed in three replicate injections 
on the LC/MS; the average of the three injections is displayed in the following figures 
and tables. 
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Figure 1: Fluidic pathway of 2D-LC system  
 
2.1.2 Standards and Reagents 
Analytical reference standards in the form of 1mg/mL solutions dissolved in 
methanol were obtained from Cerriliant (Round Rock, TX, U.S.A). They include cocaine, 
benzoylecgonine, ecgonine methyl ester, and their respective deuterated internal 
standards cocaine-D3, benzoylecgonine-D3, and ecgonine methyl ester-D3. All solvents 
utilized throughout this research, including methanol, acetonitrile, acetone, ammonium 
hydroxide, hydrochloric acid and formic acid, were Optima grade and purchased from 
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Fischer Scientific (Waltham, MA, U.S.A). All water consumed in this research for this 
research was Millie-Q grade water (Merck/Millipore Co, Darmstadt, Germany, EU). 
2.2 Method development 
2.2.1 Compound optimization 
Compound optimization was performed on all standards. Each compound was 
prepared in a 50/50 water/methanol solution at a concentration of 10µg/mL (10ppm). The 
solutions were directly infused into the mass spectrometer. Precursor ions were first 
determined by running a scan in MS1 mode.  Two product ions were then selected for 
each standard in MS/MS mode, while varying the collision energy values. The higher the 
collision energy, the more the precursor molecule is fragmented. The most intense 
transition was selected for quantification and the second most intense transition was 
selected for confirmation. The collision energy value at which the transition gave the 
highest signal was chosen. The MRM table for all analytes is included below. 
Table 1: MRM table for all compounds 
Compound Ion mode Precursor 
ion 
Cone Product ion CE 
Cocaine ESI + 304.1 30 182.1 20 
   30 82.1 30 
Benzoylecgonine ESI + 290.1 30 168.1 15 
   30 105.1 30 
Ecgonine Methyl Ester ESI + 200.1 30 182.1 20 
   30 82.1 25 
Cocaine-D3 ESI + 307.1 30 185.1 20 
   30 85.1 30 
Benzoylecgonine-D3 ESI + 293.1 30 171.1 20 
   30 105.1 30 
Ecgonine Methyl Ester-
D3 ESI + 203.1 30 185.1 20 
   30 85.1 25 
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An example of the compound optimization process for cocaine is depicted in the mass 
spectra below (Figure 2). The first chromatogram on the bottom left corner shows the 
compound cocaine, at mass 304da, is fully intact with no fragments at the lowest collision 
energy (CE) value. Then, as the collision energy increases, the product ions increase in 
intensity while the precursor ion diminishes. The remaining mass spectrometer settings 
are displayed in Table 2.  
 
 
Figure 2: Compound optimization of cocaine 
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Table 2: Mass Spectrometer settings 
Capillary 
voltage 
Cone 
voltage 
Source 
temperature  
Desolvation 
temperature 
Desolvation 
gas 
Cone gas 
3.0 kV 30 V 150
o
C 550
o
C 1100 L/hr 50 L/hr 
 
2.2.2 Chromatography method development 
A stock solution of cocaine, benzoylecgonine and ecgonine methyl ester was 
prepared at a concentration of 10µg/mL in 100% methanol. This stock solution was 
utilized to prepare serial dilutions of lower concentration stock solutions throughout this 
project. The 10µg/mL stock solution was prepared fresh each month. 
The analytical separation column used for all analyses was an ACQUITY UPLC 
HSS T3, 2.1 x 50mm, 1.7 µm (Waters Corporation, Milford, MA, U.S.A), which is a high 
strength silica C18 sorbent. The sample injection volume was set at 100µL. The sample is 
loaded with water at 0.1mL/min and diluted at 5% with water at a flow rate of 1.9 
mL/min. The mixture is loaded on the trap column at a flow rate of 2.0 mL/min. Then the 
compounds retained on the trap are refocused onto the analytical column during elution, 
which is completed with a 5 minute linear gradient from 5% of organic solvent mobile 
phase to 95% mobile phase. The total run time was 10 minutes. 
The chromatography conditions were tested on two trapping chemistries, Oasis
®
 
HLB 40mg and 80mg trap columns (Waters Corporation, Milford, MA, U.S.A). HLB 
(hydrophilic-lipophilic balance) is a strong hydrophilic, high retention strength sorbent 
material. Additionally, loading and dilution pH was optimized by testing pH 3, 7, and 10 
on the two different sized HLB trapping columns. And finally a low pH and high pH 
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loading was tested for each combination. An example of the chromatography evaluation 
scheme is pictured in Figure 3.  
A 10 ng/mL stock solution was prepared in water, methanol, and Acetonitrile and 
run on an automated process testing different parameters in a single overnight run. 
Elution consisted of two mobile phases, A and B. Mobile phase A consisted of water with 
0.5% formic acid and mobile phase B consisted of Acetonitrile with 0.5% formic acid. It 
was determined that all analytes gave the best signal intensity with a pH 10 loading and 
dilution on the 80mg HLB trap column.  
 
 
Figure 3: Methods tested for optimization of method 
Figure 4 depicts three different methods for cocaine. All three methods utilize an 
80mg HLB trapping column and low pH acetonitrile elution. The pH of the loading is 
varied in each column. There is an entire order of magnitude of difference in signal 
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intensity from the water standard to the methanol and organic standards, indicating that 
cocaine prefers to be dissolved in organic as opposed to aqueous. There is slight peak 
broadening in the standards dissolved in acetonitrile, but otherwise all methods seem to 
work well for cocaine.  
 Figure 5 depicts a similar situation to cocaine in that all methods produce 
Gaussian peak shapes and good intensities. However, when benzoylecgonine is dissolved 
in acetonitrile, there is a very apparent peak broadening. This effect could be fixed with a 
higher dilution factor before the first dimension, but methanol and water produced sharp 
peaks so no further action was taken for the acetonitrile standard. It is interesting to note 
in this set of chromatograms that the water standards actually produced higher signal 
intensities than the methanol standards, which indicates that benzoylecgonine is a more 
water-soluble compound. This indicated further action required in the extraction 
optimization discussed later.  
Finally, in Figure 6, there was only one method which produced Gaussian peak 
shapes and good intensities. Ecgonine methyl ester needs to be loaded at a high pH in 
order to see any signal whatsoever. Without the ability to evaluate many chromatography 
methods in a short time period, it would have been much more difficult to figure out why 
ecgonine methyl ester was not being detected in earlier methods.  
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Figure 4: Method optimization results for Cocaine  
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Figure 5: Method optimization results for benzoylecgonine 
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Figure 6: Method optimization results for ecgonine methyl ester 
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2.2.3 Solid phase extraction optimization 
In order to develop a sample preparation method, it was necessary to choose a 
solid phase extraction sorbent. The pKa of each compound was referenced in preparation 
for this decision. Cocaine, benzoylecgonine, and ecgonine methyl ester have pKa’s of 
8.6, 10.82, and 9.57 respectively. All compounds are basic in nature, therefore an Oasis® 
MCX solid phase extraction barrel (Waters Corporation, Milford, MA, U.S.A) was 
chosen for testing, as it is a mixed mode sorbent consisting of a strong cation exchange 
portion meant to retain ionized basic compounds and a reverse phase portion meant to 
retain acids and neutrals. For preliminary method development, two sorbent packing sizes 
of this solid phase extraction sorbent were compared. The mix of compounds was 
prepared at a concentration of 1ng/mL (1 ppb) in methanol, Acetonitrile, acetone, 50/50 
methanol and Acetonitrile, 95/5 acetonitrile and ethyl acetate, and 95/5 acetonitrile and 
Methyl tertial butyl ether—all with 5% ammonium hydroxide added. 2mL of each mix 
was dissolved in 50mL of Millipore water for loading on the 60mg MCX cartridge and 
100mL of water for the 150mg MCX cartridge. The mixture of compounds, dissolved in 
100% organic solvent, was diluted in Millipore water at a concentration of less than 5% 
so as to prevent breakthrough of the compounds on the solid phase extraction sorbent. 
The MCX cartridges were treated with two washes and then elution. Wash 1 was 0.1N 
hydrochloric acid in water, the low pH of which would ionize the basic compounds 
retained on the sorbent so they could be captured by the ion exchange portion. The 
second wash was methanol with 5% formic acid which eluted the acids and neutrals from 
the reverse phase portion of the sorbent, while leaving the ionized basic compounds on 
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the ion exchange portion. Elution was completed with the corresponding solutions 
mentioned above which range in polarity. For example, the mixture of compounds 
dissolved in methanol was also eluted from the MCX cartridge with methanol. The high 
pH of the elution solvent neutralized the compounds on the ion exchange sorbent and 
allowed them to be eluted from the sorbent. The second wash was also collected and 
analyzed to determine if breakthrough occurred at this step. It was determined that the 
150mg MCX cartridge, using methanol as the elution solvent gave the best recoveries for 
all three compounds overall so it was chosen for the final method. Additionally, the 
second wash proved to have negligible breakthrough of all compounds. 
 
Table 3: Area counts of MCX 60mg evaluation 
MCX 60mg Cocaine Benzoylecgonine Ecgonine Methyl 
Ester 
Wash 2 5497 483 747 
MeOH + 5% NH4OH 25808 2199 5515 
Wash 2 2471 99 559 
ACN + 5% NH4OH 34316 813 3187 
Wash 2 3128 41 189 
Acetone + 5% NH4OH 18699 52 8 
Wash 2 3451 194 569 
50/50 MeOH/CAN + 5% 
NH4OH 31471 1529 1371 
Wash 2 3679 73 566 
95/5 ACN/ Ethyl acetate 33225 388 1243 
Wash 2 21 36 468 
95/5 ACN/MBTE + 5% 
NH4OH 46281 699 1013 
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Table 4: Area count comparison of MCX 150mg evaluation 
MCX 150mg Cocaine Benzoylecgonine Ecgonine Methyl 
Ester 
Wash 2 28 391 98 
MeOH + 5% NH4OH 29915 10978 10366 
Wash 2 12 181 200 
ACN + 5% NH4OH 36711 3192 5833 
Wash 2 16 68 231 
Acetone + 5% NH4OH 24350 133 17 
Wash 2 14 243 249 
50/50 MeOH/CAN + 5% 
NH4OH 35306 8130 4652 
Wash 2 64 77 284 
95/5 ACN/ Ethyl acetate 39660 1138 3147 
Wash 2 22 48 375 
95/5 ACN/MBTE + 5% NH4OH 46354 896 3147 
 
2.3 Bone extraction 
2.3.1 Homogenization and solid-liquid extraction 
The next step was to develop a method for extraction of cocaine and metabolites 
from the bone tissue. A Precellys Evolution homogenizer (Bertin Technologies, 
Montigny-le-Bretonneux, France, EU) was utilized for homogenization of the bone 
samples. The homogenization is performed by loading the Precellys with 15mL tubes 
containing 4mm ceramic ball bearings (Bertin Technologies, Montigny-le-Bretonneux, 
France, EU), which are then pressurized and shaken at speed of 5000 RPM for periods of 
90 seconds at a time. In order to choose which type of ball bearings to use, one teaspoon 
of stainless steel ball bearings were placed in one tube and four 4mm ceramic ball 
bearings placed in a second tube, each containing about 0.5g of bone material and 4mL of 
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methanol. It was determined that it required 3 rounds of shaking for 90 seconds at 5000 
RPM for both the ceramic and stainless steel ball bearings to completely pulverize the 
bone into a fine powder. Both types of ball bearings performed the same function in the 
same amount of time; however it was unclear as to whether the compounds might bind to 
the ball bearings or cause any kind of suppression effect. To that end, one teaspoon of 
new stainless steel ball bearings was placed in a tube and four new ceramic ball bearings 
was placed in another as well as one teaspoon of stainless steel ball bearings and four 
ceramic ball bearings that had been used and cleaned previously were placed in two 
additional tubes. In each tube, 4mL of a 1 ng/mL (1ppb) standard mix of compounds was 
added and shaken in the Precellys, and then run through the previously developed solid 
phase extraction method. Results of this experiment showed that the mix that had been 
treated with the new and old stainless steel ball bearings produced almost half of the 
signal intensity that the ceramic ball bearing treated samples did. A comparison between 
old and used ceramic ball bearings showed no effect, which indicated that the cleaning 
method utilized in between each use was efficient. In conclusion, the ceramic ball 
bearings were chosen for completion of all further bone extractions in this research (See 
Figure 7). 
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Figure 7: Rat femur bone with ceramic ball bearings and 15mL tube used for 
homogenization 
 
After homogenization, it was necessary to choose the best extraction solvent that 
would give the highest recovery of the compounds of interest from bone. Millie-Q water, 
methanol, acetonitrile, and acetone were evaluated, each at a different pH. In each 15mL 
tube, 0.5 mL of bone material was added and 4mL of a 1 ng/mL (1ppb) mix of 
compounds was added in water, methanol, acetonitrile, or acetone. pH adjustment was 
achieved by addition of hydrochloric acid (for pH 1), ammonium hydroxide (for pH10), 
and no addition (for pH 7). After homogenization, the 15mL tubes were centrifuged at 
4000 RPM for 5 minutes. The supernatant was placed in the spin tube and centrifuged a 
second time at 4000 RMP for 5 minutes. The final extract was then diluted in 100mL of 
Millie-Q water and underwent solid phase extraction via the method previously 
described. Results indicated that a methanol extraction at pH 7, with no additives, gave 
the best intensity for cocaine. However, the intensities of benzoylecgonine and ecgonine 
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methyl ester were relatively low. The water extraction at pH 7 gave higher intensities for 
benzoylecgonine and ecgonine methyl ester, but not for cocaine (See Table 5). Therefore, 
it was concluded that two sequential extractions were necessary for optimal extraction 
efficiency. This was also indicative in the chromatography evaluation where 
benzoylecgonine gave higher intensities when it was dissolved in water. 
 
Table 5. Bone extracts – first trial 
 Cocaine Benzoylecgonine Ecgonine 
Methyl Ester 
Water Bone Spike ng/mL – pH 10 2555 2241 694 
Water Bone Spike 1ng/mL – pH 7 27886 12600 9012 
Water Bone Spike 1ng/mL – pH 3 18010 5685 6445 
MeOH Bone Spike 1 ng/mL – pH 
10 23564 3245 5852 
MeOH Bone Spike 1 ng/mL – pH 7 36409 6243 7496 
MeOH Bone Spike 1 ng/mL – pH 3 24828 2824 5256 
ACN Bone Spike 1 ng/mL – pH 10 24810 1243 5716 
ACN Bone Spike 1 ng/mL – pH 7 317 34 72 
ACN Bone Spike 1 ng/mL – pH 3 30069 2588 9333 
Acetone Bone Spike 1 ng/mL – pH 
10 3249 89 32 
Acetone Bone Spike 1 ng/mL – pH 
7 36350 355 3098 
Acetone Bone Spike 1 ng/mL – pH 
3 27454 2529 5677 
 
2.3.2 Wash step optimization 
Due to the complexity of bone as a matrix, it was necessary to evaluate whether 
additional wash steps were required in the solid phase extraction protocol. To that end, 
eight bone extractions and eight water extractions were compared—both spiked at 1 
ng/mL. Each set of water and bone had a different wash sequence. The first wash was 
always 0.1N HCl in water. The second wash varied in each set. Both single washes and 
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sequential washes were added to the protocol before the final elution was collected. The 
results of the wash evaluation are presented in Table 6. 
 
Table 6. Final elutions after different wash sequences. All washes have 5% formic 
acid additive; elution is MeOH + 5% NH4OH 
 Final elution- 
water 
extraction 
  Final 
elution- 
bone 
extraction 
  
Wash Sequence Cocaine BZE EME Cocaine BZE EME 
Un-extracted std 55861 
 
32260 12289    
Wash 2: 100% 
IPA 
44184 30767 11180 211 7 5 
Wash 2: 100% 
MeOH 
42533 28756 14500 7979 6996 3246 
Wash 2: 100% 
ACN 
41835 28448 14737 1708 1062 2350 
Wash 2: 100% 
ACE 
9231 4476 130 1251 832 441 
Wash 2: 50/50 
Water/IPA 
41146 25585 12735 7986 1888 2383 
Wash 2: 50/50 
Water/IPA 
Wash 3: 50/50 
Water/MeOH 
37541 22870 12967 12296 8009 2123 
Wash 2: 50/50 
Water/IPA 
Wash 3: 50/50 
water/MeOH 
Wash 4: 50/50 
Water/ACN 
46378 29310 12705 12674 5527 1762 
Wash 2: 50/50 
Water/IPA 
Wash 3: 50/50 
water/MeOH 
Wash 4: 50/50 
Water/ACN 
Wash 5: 50/50 
Water/ACE 
1894 9213 5805 13961 7249 787 
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If the objective of this research was to extract cocaine and its major metabolites 
from only water, the best protocol would be to add a sequential wash of 50/50 water 
isopropanol, 50/50 water and methanol, and 50/50 water and acetonitrile before the final 
elution. However, the results are very different for the bone extractions. While the 
recovery of cocaine does increase with more washes, the metabolites, particularly 
ecgonine methyl ester, decreases with every additional wash. Therefore, it was 
determined that the best protocol for all metabolites overall would be the 100% methanol 
wash only.  
2.3.3 Extraction efficiency 
In order to evaluate the efficiency of the final method, un-extracted standards, 
water extractions, and bone extractions were compared. The water extractions were 
loaded at pH 1, 7, and 10, and the final bone extracts were loaded at pH 1, 7, and 10 as 
well. Two different extraction schemes were compared for bone. The first was a 
methanol + 2% HCl extraction, followed by a water + 2% HCl extraction. The 
supernatants were pooled before dilution. The 100mL water pH was adjusted with either 
hydrochloric acid or ammonium hydroxide for pH 1 and 10 respectively. The second 
scheme was a methanol extraction followed by a water extraction with no additives. The 
supernatants were pooled, diluted, and pH adjusted before loading onto the solid phase 
extraction sorbent. With the exception of ecgonine methyl ester, the water extractions for 
cocaine and benzoylecgonine produced recoveries over 90%. There is low extraction 
efficiency for ecgonine methyl ester in both water and bone. When comparing the bone 
extractions to the water extractions, it was determined that a pH 10 load gave the best 
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overall recovery for all three compounds in comparison to the water extraction values. 
See table 7. 
 
 
 
Table 7. Un-extracted standard vs water extraction vs bone extraction at different 
loading pH  
 Cocaine Benzoylecgonine Ecgonine Methyl Ester 
Un-extracted std – 1 
ng/mL MeOH 
138434 58633 26338 
Water extraction – 1 
ng/mL spike 
   
pH 1 load 132113 57354 11875 
pH 7 load 125769 55301 11809 
pH 10 load 112949 42164 11725 
Bone extraction – 1 
ng/mL spike 
   
pH 1 load - MeOH + 
water + 2% HCl 
75568 28767 3971 
pH 1 load – MeOH + 
water – no additives 
80143 31784 9701 
pH 7 load - MeOH + 
water + 2% HCl 
62008 24017 4880 
pH 7 load – MeOH + 
water – no additives 
78449 29321 10813 
pH 10 load - MeOH + 
water + 2% HCl 
72581 30894 6569 
pH 10 load – MeOH + 
water – no additives 
97785 32071 9758 
 
It was apparent that, during method development, there was a need for a filtration 
step before the dilution step. The supernatants of the bones after homogenization and 
centrifugation still contained particles which caused the solid phase extraction to clog. 
Therefore several filters were evaluated to ensure that the compounds of interest would 
not bind or be retained on the filters and prevent optimal recovery. A centrifuge spin tube 
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containing a 0.45µm PTFE filter was chosen. After centrifugation of the bones, the 
supernatant was poured into the spin tubes and then centrifuged again at 4000 RPM for 5 
minutes. A second bone extraction was performed by adding 4mL of Millipore water to 
the already homogenized bone in the 15mL tube and shaking the mixture in the Precellys 
for an additional 90 seconds. The water extract was centrifuged again and filtered with 
spin tube. The water and methanol extracts were pooled together in a 15mL centrifuge 
tube before undergoing a centrifugation step one final time. The resulting solution was 
diluted in 100mL of water before solid phase extraction. The final extraction method is 
displayed below in figure 8. 
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Figure 8: Final extraction protocol 
2.4 Long-term Cocaine exposure to rat specimens  
All rat specimens used for this study fell under an Institutional Animal Care and 
Use Committee (IACUC) protocol. The rodents underwent 10-12 weeks chronic 
intravenous self-administration of cocaine. This was followed by a six-week period of 
abstinence, followed again by a three-week period of cocaine self-administration before 
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being euthanized. Average daily dosages for each rat fell within a range of 13-19 mg/kg. 
14 cocaine positive rats were placed outside and above ground in a gated facility for a 
period of 12 months. All recoverable skeletal samples were collected, cleaned, and stored 
at room temperature for an additional year before testing. Drug free control rat bones 
were also acquired by placing drug-free rats outdoors, above ground in the Boston 
University Forensic Anthropology Outdoor Facility (Holliston, MA, U.S.A), until full 
decomposition occurred. Bone specimens were grouped by bone type and each sample 
averaged about 0.5g. 21 femora, 20 tibio-fibula, 19 humeri + ulna combinations, and 17 
innominate bones were prepared via the final extraction method described above. 
Additionally, one humerus and ulna combination, two ulna and two radii combination, 
0.5g of vertebrae and one tibio-fibula taken from a rat immediately after being euthanized 
was analyzed for comparison. After the one year period of decomposition, all recovered 
bones were washed with water and stored in plastic containers at room temperature. The 
bones retrieved immediately after death of the rodent specimen were cleaned using a 
beetle colony to assist in consumption of the remaining soft tissue.  
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3. RESULTS  
3.1 Calibration model 
A calibration curve ranging from 0.05 ng/mL to 10 ng/mL was run in both water 
and bone on the same day as the final extractions to assist in quantitation. Calibrators 
were prepared by making a set of concentrated solutions in methanol, including 0.05 
ng/mL, 0.1 ng/mL, 0.25 ng/mL, 0.5ng/mL, 1.0 ng/mL, 2.5ng/mL, 5.0 ng/mL and 10 
ng/mL. The dilution calculations are displayed in Table 8. First, three 10 mL stock 
solutions containing cocaine, benzoylecgonine, and ecgonine methyl ester were prepared: 
Stock A = 1000 ng/mL, Stock B = 100 ng/mL, and Stock C = 10 ng/mL.  
Table 8: Calibrator concentration calculations 
 Stock solution 
volume (µL) 
Methanol volume 
(mL) 
Final concentration 
(ng/mL) 
Stock A  100 9.9 10 
 50 9.95 5 
 25 9.975 2.5 
Stock B  100 9.9 1 
 50 9.95 0.5 
 25 9.975 0.25 
Stock C  100 9.9 0.1 
 50 9.95 0.05 
 
The calibrators were used to spike 100mL water solutions as well as 0.5g bone samples. 
A full un-extracted curve containing only neat standards, a water extracted curve, and a 
bone extracted curve were analyzed on the same day as the unknown samples. 
Additionally, a blank and a recovery sample at a concentration of 1 ng/mL were run with 
the water extraction and the bone extraction. A mixture of internal standards containing 
cocaine-D3, benzoylecgonine-D3, and ecgonine methyl ester-D3 was post-spiked to all 
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final elutions at a concentration of 1 ng/mL. The recovery sample is analyzed with the 
curve as an unknown in order to calculate how accurate the curve is when analyzing an 
unknown in the same matrix. A ratio of the internal standard area count and the calibrator 
area count of each concentration was used to calculate the calibration curve equation. The 
final linear dynamic range for cocaine was 0.05ng/mL to 10ng/mL, and 0.1ng/mL to 
10ng/mL for benzoylecgonine and ecgonine methyl ester. The un-extracted standard 
calibration curve, the water extraction calibration curve (see appendix), and the bone 
extraction calibration curve all show excellent linearity with R
2
 values greater than 0.995 
(See figures 9-11).  
 
Figure 9: Calibration curve for ecgonine methyl ester  
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Figure 10: Calibration curve for benzoylecgonine 
 
 
Figure 11: Calibration curve for cocaine 
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The within curve precision was calculated using the TargetLynx software. All 
points on all curves demonstrated less than 20% deviation. The 1 ng/mL recovery sample 
for ecgonine methyl ester was calculated at 88.7% accuracy in the calibration curve, 80% 
for benzoylecgonine, and 94.3% accurate for cocaine.  
3.2 Comparison of un-extracted standards and extracted standards 
The un-extracted calibration curve was compared to the water extraction 
calibration curve and the bone extraction calibration curve in order to evaluate the 
background noise, matrix suppression, and recovery calculations. Figure H demonstrates 
chromatograms of all three compounds in all three calibration curves at a concentration 
of 0.5 ng/mL. The chromatograms demonstrate that the un-extracted standards give a 
Gaussian peak shape with little to no background noise, while the water and bone 
extractions show minor interferences and a noisy baseline. Additionally, between all 
curves, the retention time of all compounds remains consistent. 
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Figure 12: Comparison of un-extracted and extracted standard  
 
3.2.1 Matrix suppression and recovery calculations 
The following three figures demonstrate each compound with its corresponding 
internal standard for the neat standard and extracted standard curves (Figure …). The 
intensity or area count of both the compound and the internal standard is displayed as 
well as the suppression calculations, the ion ratios, the extracted recovery and un-
extracted recovery. For ecgonine methyl ester, the 0.25ng/mL concentration displayed, as 
well as the internal standard at 1 ng/mL. The chromatograms for benzoylecgonine and 
cocaine demonstrate a 1.0ng/mL analyte concentration and the internal standard post-
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spiked at 1ng/mL. The matrix suppression was calculated by comparing the intensity or 
area count of the internal standard of the neat standard and the area count of the post-
spiked internal standard of the extracted standard. The percentage difference between the 
values is the calculated suppression. The suppression effect for the 100mL Millipore 
water enrichment process is 6.3% for ecgonine methyl ester, 8.8% for benzoylecgonine, 
and 9.5% for cocaine. The suppression effect increases when the bone matrix is added to 
the equation. The bone matrix incorporation gives a suppression effect of 8.6% for 
ecgonine methyl ester, 24% for benzoylecgonine, and 21% for cocaine. It is expected that 
bone would cause a larger amount of suppression of the compounds because it is a very 
complicated matrix containing many potential interferences.  
Extraction recovery was calculated in two ways – based on a comparison of the 
area count or intensity between the neat standards and extracted standards and a 
comparison of the ion ratios of the un-extracted and extracted standards. The area counts 
of the extracted standards are compared directly to the un-extracted standard to 
demonstrate how effective the extraction method is for both water and bone compared to 
the standards used to spike them. The ion ratios are used to normalize the data and 
provide a more accurate recovery calculation between matrices. The ion ratios are 
calculated by dividing the area count of the analyte by the area count of the 
corresponding internal standard. The ion ratios were then used to calculate the recovery 
of compounds between un-extracted and extracted standards.  
The water extraction recovery was calculated using the area count and the ion 
ratio of the water extraction and that of the un-extracted standard. In the water extraction, 
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ecgonine methyl ester showed a 54% recovery based on the compound’s intensity, and a 
57% recovery based on the ion ratio. Benzoylecgonine had a 72% recovery based on the 
compound’s intensity, and an 80% recovery based on the ion ratio. Cocaine had an 85% 
recovery based on the compound’s intensity and a 94% recovery based on the ion ratio. 
The bone extraction recovery included both an un-extracted standard recovery and an 
extracted standard recovery. First the analyte area count was compared to the un-
extracted standard area count. Then, the ion ratio was compared to both the un-extracted 
standard ion ratio and the water extracted standard ion ratio, referred to as the un-
extracted standard recovery and the extracted standard recovery, respectively. The 
extracted standard recovery was included as it is a more accurate representation of the 
sample preparation method’s extraction efficiency between a very clean matrix and a 
very complicated matrix. Ecgonine methyl ester had a 39% recovery based on area count, 
an un-extracted standard recovery of 52% and an extracted standard recovery of 65%. 
Benzoylecgonine showed a 39% recovery based on area count, an un-extracted standard 
recovery of 52% and an extracted standard recovery of 65%. Cocaine had a 64% 
recovery based on area count, an un-extracted standard recovery of 81% and an extracted 
standard recovery of 86%. Overall, cocaine demonstrated the best recoveries overall. 
High recovery calculations for cocaine prove that the sample preparation method 
described in the previous chapter is very efficient at extracting and isolating cocaine from 
both a clean and very complicated matrix, though the method requires more work to 
increase extraction efficiencies of the metabolites overall. 
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Figure 13: Matrix effects and recovery calculations for ecgonine methyl ester 
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Figure 14: Matrix effects and recovery calculations for benzoylecgonine 
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Figure 15: Matrix effects and recovery calculations for cocaine 
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3.3 Quantitation of unknown samples 
The results of the calculated concentrations of the biological specimens are 
displayed in Tables 9-13, divided by bone type. Quantitation of each specimen was 
achieved by using the linear equations generated from the calibration curve in bone, 
shown above. The biological specimens include 17 innominate bones, 21 femora, 19 
humerus + ulna combinations, and 20 tibio-fibulae. Each set of bones ranged from 0.5g to 
1.0g of material. The final table depicts the bone specimens retrieved from a rodent 
carcass immediately after death. 
With the exception of cocaine, the bones analyzed at Time zero (T0) all show the 
greatest concentrations of all analytes. Ecgonine methyl ester was not detected in any 
bone analyzed after two years (T2 years). Trace level detection (TLD) indicates 
concentrations below 0.0001ng/g or 0.1pg/g.  
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Table 9: Quantitation of compounds in innominate bone 
 Cocaine 
ng/g 
Benzoylecgonine 
ng/g 
Ecgonine methyl 
ester 
ng/g 
Innominate 1 0.007 0.052 ND 
Innominate 2 TLD 0.065 ND 
Innominate 3 0.052 0.05 ND 
Innominate 4 0.005 TLD ND 
Innominate 5 0.001 0.022 ND 
Innominate 6 0.05 0.027 ND 
Innominate 7 0.001 0.033 ND 
Innominate 8 0.008 0.019 ND 
Innominate 9 TLD TLD ND 
Innominate 10 0.011 0.003 ND 
Innominate 11 0.0008 TLD ND 
Innominate 12 TLD TLD ND 
Innominate 13 TLD 0.031 ND 
Innominate 14 TLD 0.027 ND 
Innominate 15 0.009 0.032 ND 
Innominate 16 0.004 ND ND 
Innominate 17 0.0002 TLD ND 
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Table 10: Quantitation of compounds in Femora 
 Cocaine 
ng/g 
Benzoylecgonine 
ng/g 
Ecgonine methyl 
ester 
ng/g 
Femur 1 TLD TLD ND 
Femur 2 TLD 0.026 ND 
Femur 3 TLD 0.115 ND 
Femur 4 TLD 0.1 ND 
Femur 5 TLD 0.021 ND 
Femur 6 TLD 0.054 ND 
Femur 7 TLD TLD ND 
Femur 8 0.0002 0.033 ND 
Femur 9 0.04 0.024 ND 
Femur 10 0.12 0.005 ND 
Femur 11 TLD 0.013 ND 
Femur 12 TLD 0.017 ND 
Femur 13 0.008 0.019 ND 
Femur 14 0.027 0.108 ND 
Femur 15 0.013 0.056 ND 
Femur 16 0.028 0.019 ND 
Femur 17 0.021 0.112 ND 
Femur 18 0.024 TLD ND 
Femur 19 0.137 0.05 ND 
Femur 20 0.018 ND ND 
Femur 21 0.018 ND ND 
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Table 11: Quantitation of compounds in humeri and ulna 
 Cocaine 
ng/g 
Benzoylecgonine 
ng/g 
Ecgonine methyl 
ester 
ng/g 
Humerus + ulna 1 0.026 TLD ND 
Humerus + ulna 2 TLD TLD ND 
Humerus + ulna 3 TLD TLD ND 
Humerus + ulna 4 TLD TLD ND 
Humerus + ulna 5 TLD 0.014 ND 
Humerus + ulna 6 0.019 TLD ND 
Humerus + ulna 7 0.062 0.127 ND 
Humerus + ulna 8 TLD TLD ND 
Humerus + ulna 9 0.12 0.062 ND 
Humerus + ulna 10 TLD TLD ND 
Humerus + ulna 11 0.019 TLD ND 
Humerus + ulna 12 TLD ND ND 
Humerus + ulna 13 TLD ND ND 
Humerus + ulna 14 TLD ND ND 
Humerus + ulna 15 TLD ND ND 
Humerus + ulna 16 0.183 0.029 ND 
Humerus + ulna 17 0.047 0.013 ND 
Humerus + ulna 18 0.008 TLD ND 
Humerus + ulna 19 0.0005 ND ND 
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Table 12: Quantitation of compounds in tibio-fibulae 
 Cocaine 
ng/g 
Benzoylecgonine 
ng/g 
Ecgonine methyl 
ester 
ng/g 
Tibio-Fibula 1 TLD TLD ND 
Tibio-Fibula 2 TLD TLD ND 
Tibio-Fibula 3 TLD ND ND 
Tibio-Fibula 4 TLD 0.034 ND 
Tibio-Fibula 5 TLD 0.005 ND 
Tibio-Fibula 6 TLD TLD ND 
Tibio-Fibula 7 TLD 0.022 ND 
Tibio-Fibula 8 TLD TLD ND 
Tibio-Fibula 9 TLD ND ND 
Tibio-Fibula 10 0.0159 TLD ND 
Tibio-Fibula 11 TLD TLD ND 
Tibio-Fibula 12 TLD 0.017 ND 
Tibio-Fibula 13 TLD TLD ND 
Tibio-Fibula 14 0.0005 TLD ND 
Tibio-Fibula 15 TLD TLD ND 
Tibio-Fibula 16 TLD 0.017 ND 
Tibio-Fibula 17 TLD 0.020 ND 
Tibio-Fibula 18 TLD 0.026 ND 
Tibio-Fibula 19 TLD 0.010 ND 
Tibio-Fibula 20 TLD TLD ND 
 
Table 13: Quantitation of bones at T0 
 Cocaine 
ng/g 
Benzoylecgonine 
ng/g 
Ecgonine methyl 
ester 
ng/g 
Humerus + ulna 0.030 0.067 0.047 
2 Ulna + 2 radii 0.028 0.055 0.049 
Vertebrae 0.040 0.165 0.201 
Tibio-fibula 0.085 0.184 0.201 
 
Representative chromatograms of the specimens are included in Figures 16-18. The 
remaining chromatograms for all case samples can be found in Appendix A. The left 
column of chromatograms show four representative spiked bone concentrations in the 
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calibration curve, the left column of chromatograms depicts a representative bone in 
varying concentrations.  
The first figure gives a representation of cocaine detected in the vertebrae sample 
from time zero, the innominate 3, the femur 19, and the humerus + ulna 16. The 
concentrations were measured at 0.04ng/g, 0.052 ng/g, 0.137ng/g, and 0.183ng/g or 
40pg/g, 52pg/g, and 183pg/g respectively. As demonstrated, even at concentrations as 
low as 0.05ng/g or 50pg/g the baseline is very low with no interferences. This is an 
indication that the linear dynamic range of cocaine could have been extended further into 
lower concentrations. Additionally, all of the peaks are Gaussian and the retention times 
are stable. Cocaine is clearly very stable in bone for longer periods of time. 
Figure 17 represents benzoylecgonine detected in different bone types. 
Benzoylecgonine was detected in the vertebrae at time zero, the innominate 3, the femur 
14, and the humerus + ulna 7, at concentrations of 0.165ng/g, 0.050ng/g, 0.108ng/g, and 
0.127ng/g or 165pg/g, 50pg/g, 108pg/g and 127pg/g respectively. Besides the two T2 years 
samples at concentrations 0.100ng/g or 100pg/g, the rest of the T2 years samples ranged 
from 0.010ng/g to 0.050ng/g or 10pg/g to 50pg/g. The high concentration of 
benzoylecgonine in the time zero sample may indicate that benzoylecgonine has a greater 
chance of being detected in higher concentrations closer to the time of death. The lower 
concentrations may be an indication of sample degradation as well. It is also interesting 
to note that the baseline gets noisier as the concentration decreases. This indicates that the 
linear dynamic range listed for this compound was as accurate as possible. It is 
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interesting to note that the interferences vary from bone to bone, which means that each 
sample tested is different.  
Finally, Figure 18 has representative chromatograms of ecgonine methyl ester 
samples. As listed in Tables 9-12, ecgonine methyl ester was not detected in any of the T2 
years samples tested. This may indicate two things. The first is that the method developed 
for this research was not able to isolate ecgonine methyl ester from the bone successfully. 
The second possibility is that there was no ecgonine methyl ester in the bones themselves 
after two years, meaning the sample was completely degraded. The second possibility 
seems plausible as the time zero sample has the largest concentration listed of all three 
compounds. The time zero bone proves that the method can successfully isolate ecgonine 
methyl ester from bone, but the compound is most likely not very stable in bone for 
longer periods of time. 
 
  
54 
 
Figure 16: Representative chromatograms of cocaine bone samples: spiked bone on 
left, unknown samples on right  
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Figure 17: Representative chromatograms of benzoylecgonine bone samples: spiked 
bone on left, unknown samples on right  
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Figure 18: Representative chromatograms of ecgonine methyl ester bone samples: 
spiked bone on left, unknown samples on right  
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4. CONCLUSIONS 
The product of this research was development of a rapid and robust method to 
accurately detect trace levels of cocaine in bone. In rodent bone samples that underwent 
decomposition for one year, followed by one year of storage, cocaine was detected at a 
range of 0-183pg/g or 0-0.183ng/g. Benzoylecgonine was detected at a range of 0-
127pg/g or 0-0.127ng/g and ecgonine methyl ester was not detected in any of the two 
year samples. It was detected in a range of 50-201pg/g or 0.05-0.201ng/g in the time zero 
bone samples. Due to extraction efficiency issues for ecgonine methyl ester during the 
method development phase, it is unclear whether ecgonine methyl ester was totally 
absent from the bone samples or if the method was not strong enough to detect it. 
Cocaine has proven to remain detectable in bone after decomposition and storage at room 
temperature. Results that indicate trace level detection showcase a sharp, Gaussian peak 
shape for cocaine with a low baseline, however the concentration was well below the 
calibration curve generated for this data. With an even more sensitive mass spectrometer 
and a calibration curve encompassing lower concentrations, it would be possible to 
quantify cocaine in bone in the range of femtograms. This could be an advantage for 
forensic casework, since human skeletal remains are not often complete. So the ability to 
test any bone with confidence would be beneficial for future casework.  
This methodology and instrumentation could be easily incorporated into 
toxicology testing laboratories. LC/MS is already an established and court approved 
method for forensic scientists. With the addition of a pump and a trap column, sample 
preparation times could be reduced tenfold and LOQ’s and LOD’s can be potentially 
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reduced. For forensic casework, which often has very time sensitive demands, this 
technology would be an asset to any laboratory. 
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5. FUTURE DIRECTIONS 
This project could be extended further in two main ways. The first option is to use 
the established method to test rodent bones that have decomposed for shorter periods of 
time. It would be interesting to see if shorter decomposition time leads to greater 
detectable concentrations in the bones. The second option is to optimize the method even 
further to achieve greater detection of the metabolites of cocaine. For example, the 
absence of ecgonine methyl ester in the bone samples does not necessarily indicate that 
there was no metabolite present. It is possible that the developed method was unable to 
successfully isolate the metabolite from the bone itself. This method could potentially 
improve by using a different solid phase extraction sorbent than the MCX cartridge. 
Ecgonine methyl ester and benzoylecgonine are both strong bases with pKa’s around 10 
or higher. It is possible that using an elution solvent at pH10 is not basic enough to 
neutralize these compounds enough to elute from the ion exchange portion of the sorbent. 
Instead, a weak ion exchange sorbent (WXC), could be used. The WXC sorbent contains 
carboxylic acid at a pKa ~ 5. For a method utilizing WCX, strong bases would be 
captured on the ion exchange portion, and the purpose of the elution solvent would be to 
neutralize the sorbent itself instead of the compounds. Therefore, all strong bases would 
elute, regardless of the compound’s pKa.  
Another potential project would be to explore and compare detection of drugs in 
bone after one time usage and chronic usage of the drug of interest. Additionally, 
exploring other drugs in addition to cocaine in bone would be worthwhile for forensic 
investigations. Finally, from an anthropological point of view, it might be possible to 
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screen for substances anthropologists suspect may have been ingested on a daily bases in 
archaeological cases.  
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APPENDIX A:  Chromatograms of bone calibration curve and representative 
chromatograms of each sample bone type 
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